Crossmark

Sacubitril/valsartan reduces levels of procollagen types I and III and correlates with reverse cardiac remodeling

Crossref DOI link: https://doi.org/10.1016/j.rccl.2020.06.002

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Plata-Mosquera, Carlos A.

Bernal-Tórres, Wikler

Herrera-Escandón, Álvaro A.

Uribe-Posso, Laura P.

Rodríguez-Casanova, Ángela M.

Casanova-Valderrama, María E.

Vivas-Mayor, Marcela

Puerta-Mesa, Anyi C.

Martínez-Aristizabal, Jazmín
License Information

Text and Data Mining valid from 2021-01-01
More Information

This article is maintained by: Elsevier

Article Title: Sacubitril/valsartan reduces levels of procollagen types I and III and correlates with reverse cardiac remodeling

Journal Title: REC: CardioClinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rccl.2020.06.002

Content Type: article

Copyright: © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.